Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil added to intravenous regional anesthesia in forearm orthopedic surgery
IRCT20110313006044N3Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sufentanil and lidocaine in Forearm injuries (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Sensory block assessment, Motor block assessment and 3 more. Started Mar 2020; status: completed.
02
Drugs
sufentanillidocaine
03
Conditions
Forearm injuries
Beyond the preview
Go deeper on IRCT20110313006044N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110313006044N3.